Recombinant human erythropoietin in pediatric oncology: a review.
Feusner J, Hastings C
Med Pediatr Oncol 2002;39(4):463-468.
Review by Ford PA
Transfusion in premature infants impairs production and/or release of red blood cells, white blood cells and platelets.
The author concludes that suppression of erythro-, leuko- and thrombopoiesis within 48 hours after transfusion decreases the amount of precursor cells in the peripheral blood.... Read More
Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.
Kooistra MP, Kersting S, Gosriwatana I, et al.
Eur J Clin Invest 2002;32:36-41:36-41.
Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients.
The authors evaluated a low dose iron substitution scheme for the effectiveness in patients with peritoneal dialysis: 50 mg iron sucrose every other week is... Read More
Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients.
Chang CH, Chang CC, Chiang SS
Clin Nephrol 2002;57(2):136-141.
Review by Gasche C
A randomized trial of iron deficiency testing strategies in hemodialysis patients.
Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J
Kidney Int 2001;60(6):2406-2411.
Review by
The effect of i.v. iron alone or in combination with low- dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS, Blum M, Agbaria Z, et al.
Clin Nephrol 2001;55(3):212-219.
Considerations for optimal iron use for anemia due to chronic kidney disease.
Hudson JQ, Comstock TJ
Clin Ther 2001;23(10):1637-1671.
Fetal parvovirus B19 infection.
von Kaisenberg CS, Jonat W
Ultrasound Obstet Gyn 2001;18(3):280-288.
Review by Kretschmer V.